3,3-difluoro-4-(2-methylpropyl)-1-(1-propan-2-ylazetidin-3-yl)piperidine;(2R,6R)-2,6-dimethyl-1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;7-[[1-(3-methylbutyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-[[1-(2-methylpropyl)azetidin-3-yl]methyl]-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-[2-[1-(2-methylpropyl)piperidin-4-yl]ethyl]-4-propan-2-ylpiperazine;7-[[1-(2-methylpropyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-(2-methylpropyl)-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-(2-methylpropyl)-3-propan-2-yloxyazetidine;1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine

C156H309F2N21O3 — CID 165041412

IUPAC3,3-difluoro-4-(2-methylpropyl)-1-(1-propan-2-ylazetidin-3-yl)piperidine;(2R,6R)-2,6-dimethyl-1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;7-[[1-(3-methylbutyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-[[1-(2-methylpropyl)azetidin-3-yl]methyl]-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-[2-[1-(2-methylpropyl)piperidin-4-yl]ethyl]-4-propan-2-ylpiperazine;7-[[1-(2-methylpropyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-(2-methylpropyl)-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-(2-methylpropyl)-3-propan-2-yloxyazetidine;1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine
SMILESCC(C)CC1CCN(C2CN(C(C)C)C2)CC1(F)F.CC(C)CCN1CCC(CN2CCC3(CC2)CC(OC(C)C)C3)CC1.CC(C)CN1CC(CN2CCC3(CC2)CN(C(C)C)C3)C1.CC(C)CN1CC(OC(C)C)C1.CC(C)CN1CCC(CCN2CCN(C(C)C)CC2)CC1.CC(C)CN1CCC(CN2CCC3(CC2)CC(OC(C)C)C3)CC1.CC(C)CN1CCC2(CC1)CN(C(C)C)C2.CC(C)CN1CCN(CCC2CCN(C(C)C)CC2)CC1.CC(C)CN1[C@H](C)CN(CCC2CCN(C(C)C)CC2)C[C@H]1C
InChIInChI=1S/C22H42N2O.C21H40N2O.C20H41N3.C18H35N3.2C18H37N3.C15H28F2N2.C14H28N2.C10H21NO/c1-18(2)5-10-23-11-6-20(7-12-23)17-24-13-8-22(9-14-24)15-21(16-22)25-19(3)4;1-17(2)15-22-9-5-19(6-10-22)16-23-11-7-21(8-12-23)13-20(14-21)24-18(3)4;1-16(2)13-23-18(5)14-21(15-19(23)6)10-7-20-8-11-22(12-9-20)17(3)4;1-15(2)9-20-11-17(12-20)10-19-7-5-18(6-8-19)13-21(14-18)16(3)4;1-16(2)15-20-13-11-19(12-14-20)8-5-18-6-9-21(10-7-18)17(3)4;1-16(2)15-20-9-6-18(7-10-20)5-8-19-11-13-21(14-12-19)17(3)4;1-11(2)7-13-5-6-18(10-15(13,16)17)14-8-19(9-14)12(3)4;1-12(2)9-15-7-5-14(6-8-15)10-16(11-14)13(3)4;1-8(2)5-11-6-10(7-11)12-9(3)4/h18-21H,5-17H2,1-4H3;17-20H,5-16H2,1-4H3;16-20H,7-15H2,1-6H3;15-17H,5-14H2,1-4H3;2*16-18H,5-15H2,1-4H3;11-14H,5-10H2,1-4H3;12-13H,5-11H2,1-4H3;8-10H,5-7H2,1-4H3/t;;18-,19-;;;;;;/m..1....../s1
InChIKeyOEMKJQLLQIQKPI-CNHSLCBISA-N
MW2565.33 g/mol
LogP27.19
Rot. Bonds47

About 3,3-difluoro-4-(2-methylpropyl)-1-(1-propan-2-ylazetidin-3-yl)piperidine;(2R,6R)-2,6-dimethyl-1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;7-[[1-(3-methylbutyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-[[1-(2-methylpropyl)azetidin-3-yl]methyl]-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-[2-[1-(2-methylpropyl)piperidin-4-yl]ethyl]-4-propan-2-ylpiperazine;7-[[1-(2-methylpropyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-(2-methylpropyl)-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-(2-methylpropyl)-3-propan-2-yloxyazetidine;1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine

3,3-difluoro-4-(2-methylpropyl)-1-(1-propan-2-ylazetidin-3-yl)piperidine;(2R,6R)-2,6-dimethyl-1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;7-[[1-(3-methylbutyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-[[1-(2-methylpropyl)azetidin-3-yl]methyl]-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-[2-[1-(2-methylpropyl)piperidin-4-yl]ethyl]-4-propan-2-ylpiperazine;7-[[1-(2-methylpropyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-(2-methylpropyl)-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-(2-methylpropyl)-3-propan-2-yloxyazetidine;1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine (PubChem CID 165041412) has the molecular formula C156H309F2N21O3 and a molecular weight of 2565.33 g/mol. Its IUPAC name is 3,3-difluoro-4-(2-methylpropyl)-1-(1-propan-2-ylazetidin-3-yl)piperidine;(2R,6R)-2,6-dimethyl-1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;7-[[1-(3-methylbutyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-[[1-(2-methylpropyl)azetidin-3-yl]methyl]-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-[2-[1-(2-methylpropyl)piperidin-4-yl]ethyl]-4-propan-2-ylpiperazine;7-[[1-(2-methylpropyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-(2-methylpropyl)-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-(2-methylpropyl)-3-propan-2-yloxyazetidine;1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine.

Molecular Properties

Compound Name3,3-difluoro-4-(2-methylpropyl)-1-(1-propan-2-ylazetidin-3-yl)piperidine;(2R,6R)-2,6-dimethyl-1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;7-[[1-(3-methylbutyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-[[1-(2-methylpropyl)azetidin-3-yl]methyl]-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-[2-[1-(2-methylpropyl)piperidin-4-yl]ethyl]-4-propan-2-ylpiperazine;7-[[1-(2-methylpropyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-(2-methylpropyl)-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-(2-methylpropyl)-3-propan-2-yloxyazetidine;1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine
PubChem CID165041412
Molecular FormulaC156H309F2N21O3
Molecular Weight2565.33 g/mol
Exact Mass2563.46
IUPAC Name3,3-difluoro-4-(2-methylpropyl)-1-(1-propan-2-ylazetidin-3-yl)piperidine;(2R,6R)-2,6-dimethyl-1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;7-[[1-(3-methylbutyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-[[1-(2-methylpropyl)azetidin-3-yl]methyl]-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-[2-[1-(2-methylpropyl)piperidin-4-yl]ethyl]-4-propan-2-ylpiperazine;7-[[1-(2-methylpropyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-(2-methylpropyl)-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-(2-methylpropyl)-3-propan-2-yloxyazetidine;1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine
SMILESCC(C)CC1CCN(C2CN(C(C)C)C2)CC1(F)F.CC(C)CCN1CCC(CN2CCC3(CC2)CC(OC(C)C)C3)CC1.CC(C)CN1CC(CN2CCC3(CC2)CN(C(C)C)C3)C1.CC(C)CN1CC(OC(C)C)C1.CC(C)CN1CCC(CCN2CCN(C(C)C)CC2)CC1.CC(C)CN1CCC(CN2CCC3(CC2)CC(OC(C)C)C3)CC1.CC(C)CN1CCC2(CC1)CN(C(C)C)C2.CC(C)CN1CCN(CCC2CCN(C(C)C)CC2)CC1.CC(C)CN1[C@H](C)CN(CCC2CCN(C(C)C)CC2)C[C@H]1C
InChIInChI=1S/C22H42N2O.C21H40N2O.C20H41N3.C18H35N3.2C18H37N3.C15H28F2N2.C14H28N2.C10H21NO/c1-18(2)5-10-23-11-6-20(7-12-23)17-24-13-8-22(9-14-24)15-21(16-22)25-19(3)4;1-17(2)15-22-9-5-19(6-10-22)16-23-11-7-21(8-12-23)13-20(14-21)24-18(3)4;1-16(2)13-23-18(5)14-21(15-19(23)6)10-7-20-8-11-22(12-9-20)17(3)4;1-15(2)9-20-11-17(12-20)10-19-7-5-18(6-8-19)13-21(14-18)16(3)4;1-16(2)15-20-13-11-19(12-14-20)8-5-18-6-9-21(10-7-18)17(3)4;1-16(2)15-20-9-6-18(7-10-20)5-8-19-11-13-21(14-12-19)17(3)4;1-11(2)7-13-5-6-18(10-15(13,16)17)14-8-19(9-14)12(3)4;1-12(2)9-15-7-5-14(6-8-15)10-16(11-14)13(3)4;1-8(2)5-11-6-10(7-11)12-9(3)4/h18-21H,5-17H2,1-4H3;17-20H,5-16H2,1-4H3;16-20H,7-15H2,1-6H3;15-17H,5-14H2,1-4H3;2*16-18H,5-15H2,1-4H3;11-14H,5-10H2,1-4H3;12-13H,5-11H2,1-4H3;8-10H,5-7H2,1-4H3/t;;18-,19-;;;;;;/m..1....../s1
InChIKeyOEMKJQLLQIQKPI-CNHSLCBISA-N
XLogP27.19
TPSA95.73 Ų
H-Bond Donors
H-Bond Acceptors24
Rotatable Bonds47
Heavy Atoms182
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002565.33
LogP ≤ 527.19
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1024

Analyze 3,3-difluoro-4-(2-methylpropyl)-1-(1-propan-2-ylazetidin-3-yl)piperidine;(2R,6R)-2,6-dimethyl-1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;7-[[1-(3-methylbutyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-[[1-(2-methylpropyl)azetidin-3-yl]methyl]-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-[2-[1-(2-methylpropyl)piperidin-4-yl]ethyl]-4-propan-2-ylpiperazine;7-[[1-(2-methylpropyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-(2-methylpropyl)-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-(2-methylpropyl)-3-propan-2-yloxyazetidine;1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3,3-difluoro-4-(2-methylpropyl)-1-(1-propan-2-ylazetidin-3-yl)piperidine;(2R,6R)-2,6-dimethyl-1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;7-[[1-(3-methylbutyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-[[1-(2-methylpropyl)azetidin-3-yl]methyl]-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-[2-[1-(2-methylpropyl)piperidin-4-yl]ethyl]-4-propan-2-ylpiperazine;7-[[1-(2-methylpropyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-(2-methylpropyl)-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-(2-methylpropyl)-3-propan-2-yloxyazetidine;1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine?
The IUPAC name of 3,3-difluoro-4-(2-methylpropyl)-1-(1-propan-2-ylazetidin-3-yl)piperidine;(2R,6R)-2,6-dimethyl-1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;7-[[1-(3-methylbutyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-[[1-(2-methylpropyl)azetidin-3-yl]methyl]-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-[2-[1-(2-methylpropyl)piperidin-4-yl]ethyl]-4-propan-2-ylpiperazine;7-[[1-(2-methylpropyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-(2-methylpropyl)-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-(2-methylpropyl)-3-propan-2-yloxyazetidine;1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine (CID 165041412) is 3,3-difluoro-4-(2-methylpropyl)-1-(1-propan-2-ylazetidin-3-yl)piperidine;(2R,6R)-2,6-dimethyl-1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;7-[[1-(3-methylbutyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-[[1-(2-methylpropyl)azetidin-3-yl]methyl]-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-[2-[1-(2-methylpropyl)piperidin-4-yl]ethyl]-4-propan-2-ylpiperazine;7-[[1-(2-methylpropyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-(2-methylpropyl)-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-(2-methylpropyl)-3-propan-2-yloxyazetidine;1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine.
What is the SMILES notation for 3,3-difluoro-4-(2-methylpropyl)-1-(1-propan-2-ylazetidin-3-yl)piperidine;(2R,6R)-2,6-dimethyl-1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;7-[[1-(3-methylbutyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-[[1-(2-methylpropyl)azetidin-3-yl]methyl]-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-[2-[1-(2-methylpropyl)piperidin-4-yl]ethyl]-4-propan-2-ylpiperazine;7-[[1-(2-methylpropyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-(2-methylpropyl)-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-(2-methylpropyl)-3-propan-2-yloxyazetidine;1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine?
The canonical SMILES for 3,3-difluoro-4-(2-methylpropyl)-1-(1-propan-2-ylazetidin-3-yl)piperidine;(2R,6R)-2,6-dimethyl-1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;7-[[1-(3-methylbutyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-[[1-(2-methylpropyl)azetidin-3-yl]methyl]-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-[2-[1-(2-methylpropyl)piperidin-4-yl]ethyl]-4-propan-2-ylpiperazine;7-[[1-(2-methylpropyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-(2-methylpropyl)-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-(2-methylpropyl)-3-propan-2-yloxyazetidine;1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine is CC(C)CC1CCN(C2CN(C(C)C)C2)CC1(F)F.CC(C)CCN1CCC(CN2CCC3(CC2)CC(OC(C)C)C3)CC1.CC(C)CN1CC(CN2CCC3(CC2)CN(C(C)C)C3)C1.CC(C)CN1CC(OC(C)C)C1.CC(C)CN1CCC(CCN2CCN(C(C)C)CC2)CC1.CC(C)CN1CCC(CN2CCC3(CC2)CC(OC(C)C)C3)CC1.CC(C)CN1CCC2(CC1)CN(C(C)C)C2.CC(C)CN1CCN(CCC2CCN(C(C)C)CC2)CC1.CC(C)CN1[C@H](C)CN(CCC2CCN(C(C)C)CC2)C[C@H]1C.
What is the InChIKey of 3,3-difluoro-4-(2-methylpropyl)-1-(1-propan-2-ylazetidin-3-yl)piperidine;(2R,6R)-2,6-dimethyl-1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;7-[[1-(3-methylbutyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-[[1-(2-methylpropyl)azetidin-3-yl]methyl]-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-[2-[1-(2-methylpropyl)piperidin-4-yl]ethyl]-4-propan-2-ylpiperazine;7-[[1-(2-methylpropyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-(2-methylpropyl)-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-(2-methylpropyl)-3-propan-2-yloxyazetidine;1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine?
The InChIKey is OEMKJQLLQIQKPI-CNHSLCBISA-N. The full InChI is InChI=1S/C22H42N2O.C21H40N2O.C20H41N3.C18H35N3.2C18H37N3.C15H28F2N2.C14H28N2.C10H21NO/c1-18(2)5-10-23-11-6-20(7-12-23)17-24-13-8-22(9-14-24)15-21(16-22)25-19(3)4;1-17(2)15-22-9-5-19(6-10-22)16-23-11-7-21(8-12-23)13-20(14-21)24-18(3)4;1-16(2)13-23-18(5)14-21(15-19(23)6)10-7-20-8-11-22(12-9-20)17(3)4;1-15(2)9-20-11-17(12-20)10-19-7-5-18(6-8-19)13-21(14-18)16(3)4;1-16(2)15-20-13-11-19(12-14-20)8-5-18-6-9-21(10-7-18)17(3)4;1-16(2)15-20-9-6-18(7-10-20)5-8-19-11-13-21(14-12-19)17(3)4;1-11(2)7-13-5-6-18(10-15(13,16)17)14-8-19(9-14)12(3)4;1-12(2)9-15-7-5-14(6-8-15)10-16(11-14)13(3)4;1-8(2)5-11-6-10(7-11)12-9(3)4/h18-21H,5-17H2,1-4H3;17-20H,5-16H2,1-4H3;16-20H,7-15H2,1-6H3;15-17H,5-14H2,1-4H3;2*16-18H,5-15H2,1-4H3;11-14H,5-10H2,1-4H3;12-13H,5-11H2,1-4H3;8-10H,5-7H2,1-4H3/t;;18-,19-;;;;;;/m..1....../s1.
What are the key properties of 3,3-difluoro-4-(2-methylpropyl)-1-(1-propan-2-ylazetidin-3-yl)piperidine;(2R,6R)-2,6-dimethyl-1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;7-[[1-(3-methylbutyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-[[1-(2-methylpropyl)azetidin-3-yl]methyl]-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-[2-[1-(2-methylpropyl)piperidin-4-yl]ethyl]-4-propan-2-ylpiperazine;7-[[1-(2-methylpropyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-(2-methylpropyl)-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-(2-methylpropyl)-3-propan-2-yloxyazetidine;1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine?
3,3-difluoro-4-(2-methylpropyl)-1-(1-propan-2-ylazetidin-3-yl)piperidine;(2R,6R)-2,6-dimethyl-1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;7-[[1-(3-methylbutyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-[[1-(2-methylpropyl)azetidin-3-yl]methyl]-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-[2-[1-(2-methylpropyl)piperidin-4-yl]ethyl]-4-propan-2-ylpiperazine;7-[[1-(2-methylpropyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-(2-methylpropyl)-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-(2-methylpropyl)-3-propan-2-yloxyazetidine;1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine has a molecular weight of 2565.33 g/mol, XLogP of 27.19, 47 rotatable bonds, 0 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 3,3-difluoro-4-(2-methylpropyl)-1-(1-propan-2-ylazetidin-3-yl)piperidine;(2R,6R)-2,6-dimethyl-1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine;7-[[1-(3-methylbutyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-[[1-(2-methylpropyl)azetidin-3-yl]methyl]-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-[2-[1-(2-methylpropyl)piperidin-4-yl]ethyl]-4-propan-2-ylpiperazine;7-[[1-(2-methylpropyl)piperidin-4-yl]methyl]-2-propan-2-yloxy-7-azaspiro[3.5]nonane;7-(2-methylpropyl)-2-propan-2-yl-2,7-diazaspiro[3.5]nonane;1-(2-methylpropyl)-3-propan-2-yloxyazetidine;1-(2-methylpropyl)-4-[2-(1-propan-2-ylpiperidin-4-yl)ethyl]piperazine is sourced from PubChem (CID 165041412), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).